Med Page Today
MAY 22, 2024
(MedPage Today) -- A diet high in ultra-processed foods upped the risk of cognitive impairment or stroke, data from the prospective REGARDS study showed. However, risk of either cognitive decline or stroke fell for people who had higher intake.
Science Daily - Stroke
MAY 22, 2024
Extreme heat and extreme cold are both associated with increased risks of death from ischemic and hemorrhagic stroke, according to a new study. The researchers found that the link between extreme temperatures and stroke mortality was stronger in low-income countries than in high-income countries.
Science Daily - Heart Disease
MAY 22, 2024
Researchers have mapped the immune response in heart attacks and identified signatures that correlate with the clinical progression.
Science Daily - Stroke
MAY 22, 2024
People who eat more ultra-processed foods like soft drinks, chips and cookies may have a higher risk of having memory and thinking problems and having a stroke than those who eat fewer processed foods, according to a new study. The study does not prove that eating ultra-processed foods causes memory and thinking problems and stroke. It only shows an association.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
MAY 22, 2024
A recent study suggests that high ultraprocessed food consumption in preschool children is linked to increased cardiometabolic risk factors.
Dr. Smith's ECG Blog
MAY 22, 2024
Written by Sean Trostel MD I returned to my desk after seeing a patient and saw this screening ECG sitting on my desk to be read. The patient was a man in his 80s with chief complaint listed as: "hyperglycemia, weakness, ground level fall." ECG #1 @ 15:30 What do you think? Slow, irregular rhythm - likely slow atrial fibrillation Very wide QRS measuring ~180 ms in some leads, not fitting LBBB morphology and wider than vast majority of LBBB No signs of OMI, no modified Sgarbossa criteria Peaked T
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MAY 22, 2024
Announced on May 22, 2024, the Roche Diagnostics Tina-quant® Lp(a) assay measures lipoprotein (a) in a person’s bloodstream to evaluate cardiovascular risk.
Med Page Today
MAY 22, 2024
(MedPage Today) -- Concerns over hypoglycemia risk with an investigational once-weekly insulin product in patients with type 1 diabetes prompted the FDA to call an advisory committee together to weigh in on the matter. On Friday, the Endocrinologic.
Dr. Paddy Barrett
MAY 22, 2024
I want to give you the best opportunity to have optimal cardiovascular health. Most people want the highest-yield information to improve their heart health. Some people want the full masterclass, but most people just want the core content. The Heart Health Formula is the masterclass. And while it has EVERYTHING you need, it does take some time to get through it.
American College of Cardiology
MAY 22, 2024
Reduction in low-density lipoprotein cholesterol (LDL-C) levels has consistently demonstrated a reduced risk of atherosclerotic cardiovascular disease (ASCVD). There is extensive evidence from randomized trials that demonstrates the effectiveness of lipid-lowering agents in reducing ASCVD-related events.
NEJM Journal Watch - Cardiology
MAY 22, 2024
Observational data from South Korea show an association between early rhythm control and lower risk for dementia in stroke survivors.
American College of Cardiology
MAY 22, 2024
What are the risks and benefits of ticagrelor monotherapy or clopidogrel monotherapy compared with standard dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI)?
Frontiers in Cardiovascular Medicine
MAY 22, 2024
Modelling human diseases serves as a crucial tool to unveil underlying mechanisms and pathophysiology. Takotsubo syndrome (TS), an acute form of heart failure resembling myocardial infarction, manifests with reversible regional wall motion abnormalities (RWMA) of the ventricles. Despite its mortality and clinical similarity to myocardial infarction, TS aetiology remains elusive, with stress and catecholamines playing central roles.
Cardiovascular Diabetology
MAY 22, 2024
Numerous meta-analyses have explored the association between the triglyceride-glucose (TyG) index and diverse health outcomes, yet the comprehensive assessment of the scope, validity, and quality of this evide.
HCPLive
MAY 22, 2024
This retrospective, systematic review highlighted the lack of studies specifically addressing the needs of patients with inverse psoriasis.
American College of Cardiology
MAY 22, 2024
What is the effect of andexanet alfa, a reversal agent for factor Xa inhibitors, on hematoma volume expansion in patients with intracerebral hemorrhage?
HCPLive
MAY 22, 2024
Krugliak Cleveland explains findings from research she presented at DDW comparing intestinal ultrasound and conventional approaches to disease monitoring in IBD.
American College of Cardiology
MAY 22, 2024
In this week’s View, Dr. Eagle looks at transcatheter-based intervention for tetraology of Fallot. He then examines how a small left ventricle in patients with atrial fibrillation is associated with increased cardiovascular risk.
HCPLive
MAY 22, 2024
A systematic review presented at AAPA 2024 showed insignificant differences in treatment outcomes between oral JAK inhibitors and oral steroids based on alopecia outcomes like SALT.
All About Cardiovascular System and Disorders
MAY 22, 2024
About a fifth of all ischemic strokes are attributed to embolization of ruptured atherosclerotic plaque from carotid arterial stenosis. But it has been difficult to predict which person with asymptomatic carotid artery stenosis is likely to progress to symptomatic carotid disease and stroke. Now there is evidence linking clonal hematopoiesis, carotid stenosis and stroke.
HCPLive
MAY 22, 2024
Sisson discusses the adoption of 2021 ATS / ERS guidelines, as well as the need for complementary testing and imagine to contextualize the full pulmonary patient.
Frontiers in Cardiovascular Medicine
MAY 22, 2024
IntroductionPulmonary hypertension (PH) is a pathological condition that affects approximately 1% of the population. The prognosis for many patients is poor, even after treatment. Our knowledge about the pathophysiological mechanisms that cause or are involved in the progression of PH is incomplete. Additionally, the mechanism of action of many drugs used to treat pulmonary hypertension, including sotatercept, requires elucidation.MethodsUsing our graph-powered knowledge mining software Lifelike
HCPLive
MAY 22, 2024
Michael Koren, MD, discusses the recently released results from the VICTORIAN-INITIATE (V-INITIATE) trial, which were presented at the 2024 American College of Cardiology (ACC) Annual Scientific Session in Atlanta.
CardiacWire
MAY 22, 2024
It might have been graduation time in many parts of Boston last weekend, but an electrophysiology family reunion was taking place in the city’s Seaport district, bringing the latest in EP science, technology, and patient care. We hope everyone who attended HRS 2024 had a blast, and we hope all of you enjoy these top-six takeaways from electrophysiology’s biggest weekend of the year.
HCPLive
MAY 22, 2024
Michael Koren, MD, discusses the recently released results from the VICTORIAN-INITIATE (V-INITIATE) trial, which were presented at the 2024 American College of Cardiology (ACC) Annual Scientific Session in Atlanta.
Med Page Today
MAY 22, 2024
(MedPage Today) -- For patients with failed bioprosthetic surgical valves, the choice of valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) carried upfront advantages, but was ultimately associated with a higher risk of late mortality.
HCPLive
MAY 22, 2024
Erin Michos, MD, highlights several notable emerging lipid-lowering treatments, including bempedoic acid, the ANGPTL3 inhibitor evinacumab, the MTP inhibitor lomitapide, the ApoB-100 inhibitor mipomersen, and the ApoC-III degradation molecules volanesorsen and olezarsen.
Med Page Today
MAY 22, 2024
A 68-year-old man visited his doctor about a lesion that developed on his mouth over the prior 2 months. On examination, a large, purple papule was seen on his lateral tongue.
HCPLive
MAY 22, 2024
Pre-dose IOP outcomes in eyes with DME receiving intravitreal aflibercept 8 mg or 2 mg were comparable and remained stable through Week 48.
DAIC
MAY 22, 2024
milla1cf Wed, 05/22/2024 - 07:00 May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis. Building further on several years of a fruitful cooperation, the two companies are now formally joining forces to provide full scope integral services for clinical trials with AI-powered
HCPLive
MAY 22, 2024
Medical experts discuss their approach to characterizing asthma, whether they employ a dichotomous classification based on eosinophilic (EOS) or non-eosinophilic driven inflammation, or consider multiple endotypes simultaneously.
DAIC
MAY 22, 2024
milla1cf Wed, 05/22/2024 - 08:00 May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham , shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC), a marker of atherosclerotic cardiovascular disease.
HCPLive
MAY 22, 2024
Sande Okelo, MD, explores the use of corticosteroids and the implications of their long-term use, taking into account the patient quality of life and other factors when determining which patients would derive significant benefit from corticosteroid treatment.
The American Journal of Cardiology
MAY 22, 2024
Publication date: Available online 21 May 2024 Source: The American Journal of Cardiology Author(s): Kristopher Aten, Deitrich Gerlt, Zachary Rosol, Subhash Banerjee
HCPLive
MAY 22, 2024
Rezaie reviews findings from a prospective clinical trial of a novel palatable elemental diet, highlighting its 100% compliance rate and strong efficacy.
GEMMS
MAY 22, 2024
Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Through the utilization of early detection and screening technologies, healthcare startups are leading the way in developing predictive and analytical tools to accurately assess the risk of developing heart disorders.
Expert insights. Personalized for you.
132 
Let's personalize your content